Candel Therapeutics
Candel develops cancer immunotherapies designed to improve the lives of cancer patients and their families. The company's immunotherapies focus on preventing the recurrence and progression of cancer with low toxicity level which is well suited for the treatment of less aggressive or slower growing cancers such as newly diagnosed prostate cancer, enabling physicians to ensure improved outcomes for their patients and help them recover faster.
Domain
candeltx.com
Country
United StatesIndustry
BiotechnologyEmployees
11-50
Last Funding
$50.0M
Founded
1998
Tech Stack (14 technologies)
Frequently Asked Questions
What technologies does Candel Therapeutics use?+
Candel Therapeutics uses 14 technologies including Google Analytics, Google Tag Manager, HubSpot CMS Hub.
What industry is Candel Therapeutics in?+
Candel Therapeutics operates in the Biotechnology industry.
Where is Candel Therapeutics based?+
Candel Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026